|
Title
|
Authors
|
| Bone penetration of intravenous flucloxacillin and gentamicin as antibiotic prophylaxis during total hip and knee arthroplasty. |
Torkington MS, Davison MJ, Wheelwright EF, Jenkins PJ, Anthony I, Lovering AM, Blyth M, Jones B. Bone Joint J. 2017 Mar;99-B(3):358-364 |
| Therapeutic drug monitoring in the past 40 years of the Journal of Antimicrobial Chemotherapy. |
Reeves D, Lovering A, Thomson A. J Antimicrob Chemother. 2016 Dec;71(12):3330-3332 |
| Amikacin use and therapeutic durg monitoring in adults: do dose regimens and drug exposures affect ither outcome or advers events? A systematic review |
Jenkins, A, Thomson AH, Brown NM, Semple Y, Sluman C, Macgowan A, Lovering AM, Wiffen PJ; (BSAC Working Party on Therapeutic Drug Monitoring)
J Antimicrob Chemother. 2016 Jul 11 |
| A review of the pharmacokinetics and pharmacodynamics of aztreonam |
Ramsey C, MacGowan AP
J Antimicrob Chemother. 2016 June 21 |
| Differences in the pharmacodynamics of ceftaroline against different species of Enterobacteriaceae studied in an in vitro pharmacokinetic model of infection |
Bowker KE, Noel AR, Tomaselli S, MacGowan AP
J Antimicrob Chemother. 2016 May;71(5):1270-8 |
| The three wise monkeys of therapeutic drug monitoring. |
AM Lovering, T Elston. www.rcpath.org.uk April 2016 Issue 174 |
| The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriacese in in vitro pharmacokenetic/pharmacodynamic model experiments |
Albur MS, Noel A, Bowker K, MacGowan A.
Int J Antimicrob Agents. 2015 Nov;46(5):560-7 |
| Pharmacodynamics of Ceftolozane plus Tazobactam studied in an in vitro Pharmacokinetic model of infection |
MacGowan AP, Noel AR, Tomaselli SG, Nicholls D, Bowker KE
Antimicrob Agents Chemother. 2015 Nov 9;60(1):515-21 |
| Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia |
Mpenge MA, MacGowan AP
Ther Clin Risk Manag. 2015 Apr 7;11:565-79 |
| Pharmacodynamics of ceftaroline against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection |
MacGown AP, Noel AR, Tomaselli S, Bowker KE
Antimicrob Agents Chemother. 2013 Jun;57(6):2451-6 |
| Comparative antibacterial effects of moxifloxacin and levofloxacin on Streptococcus pneumoniae strains with defined mechanisms of resistance: impact of bacterial inoculum |
Bowker KE, Garvey MI, Noel AR, Tomaselli SG, Macgowan AP
J Antimicrob Chemother. 2013 May;68(5):1130-8 |
| Pharmacodynamics of the antibacterial effect of and emergence of resistance to doripenem in Pseudomonas aeruginosa and Acinetobacter baumannii in an in vitro pharmacokinetic model |
Bowker KE, Noel AR, Tomaselli SG, Elliott H, Macgowan AP
Antimicrob Agents Chemother. 2012 Oct;56(10):5009-15 |
| Bactericidal activity of multiple combinations of tigecycline and colistin against NDM-1-producing Enterobacteriacese |
Albur M, Moel A, Bowker K, MacGowan A
Antimicrob Agents Chemother. 2012 Jun;56(6):3441-3 |
| The role of pharmacokinetics/pharmacodynamics in setting clincial MIC breakpionts: the EUCAST approach |
Mouton JW, Brown DF, Apfalter P, Canton R, Giske CG, Ivanova M, Macgowan AP, Rodloff A, Soussy CJ, Steinbakk M, Kahlmeter G
Clin Microbiol Infect. 2012 Mar;18(3):E37-45 |
| Role of early intravenos to oral antibiotic switch therapy in the management of prosthetic hip infection treated with one- or two- stage relacement |
Darley ES, Bannister GC, Blom AW, MacGowan AP, Jacobsen SK, Alfouzan W
J Antimicrob Chemother 2011 Oct;66(10):2405-8 |
| Pharmacodynamics of razupenem (PZ601) studied in an in vitro pharmacokinetic model of infection |
MacGown AP, Noel A, Tomaselli S, Elliott H,
Bowker K.
Antimicrob Agents Chemother. 2011 Apr;55(4):1436-42 |
| Pharmacodynamics of telavancin studied in an in vitro pharmacokinetic model of infection |
MAcGowan AP, Noel A, Tomaselli S, Elliott H, Bowker KE.
Antimicrob Agents Chemother. 2011 Feb;55(2):867-73 |
| Analyses of teicoplanin concentrations from 1994 to 2006 from a UK assay service |
Tobin CM, Lovering AM, Sweeney E, MacGowan AP
J Antimicrob Chemother 2010 Oct;65(10):2155-7 |
| Pharmacokinetic evaluation of linezolid in patients with major thermal injuries |
Le Floch R, Amould JF, Vinsonneau C, Hovsepian L, Stephanazzi J, Bret P, Birraux G, Lovering AM
Pathol Biol (Paris) 2010 Apr;58(2):e27-31 |
| Daptomycin in synovial fluid during treatment of methicillin-resistant Staphylococcus aureus septic arthritis |
Ritchie ND, Lovering AM, Seaton RA
J Antimicrob Chemother 2010 Jun;65(6): 1314-5 |
| Potentially dangerous misuse of the Hartford once-daily nomogram for gentamicin |
Lovering AM, Reeves DS
J Antimicrob Chemother 2009 Nov;64(5): 1117-8 |
| Concentration and bioavailability of ciprofloxacin and teicoplanin in the cornea |
Kaye SB, Neal T, Nicholson S, Szkurlat J, Bamber S, Baddon AC, Anderson S, Seddon K, Dwyer N, Lovering AM, Smith G
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3176-84 |
| Pharmacokinetic evaluation of linezolid in patients with major thermal injuries |
Lovering AM, Le Floch R, Hovsepian L, Stephanazzi J, Bret P, Birraux G, Vinsonneau CJ
Antimicrob Chemother 2009 Mar;63(3):553-9 |
| Potentially dangerous use of the Hartford nomogram |
Lovering AM, Reeves DS
J Antimicrob Chemother 2009 Nov;64(5):1117-8 |
| Pharmacokinetic evaluation of patients with major thermal injuries |
Le Floch R, Arnould JF, Vinsonneau C, Hovsepian L, Stephanazzi J, Bret P, Birraux G, Lovering AM
Pathol Biol (Paris) 2009 Oct 23 & J Antimicrob Chemother 2009 Mar;63(3):553-9 |
| Concentration and bioavailability of ciprofloxacin and teicoplanin in the cornea |
Lovering AM, Le Floch R, Hovsepian L, Stephanazzi J, Bret P, Birraux G, Vinsonneau C
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3176-84 |
| The effect of a modified posterior approach on blood flow to the femoral head during hip resurfacing |
Khan A, Lovering AM, Bannister GC, Spencer RF, Kalap N
Hip Int 2009 19, 52-7 |
| Concentration and bioavailability of ciprofloxacin and teicoplanin in the cornea |
Kaye SB, Neal T, Nicholson S, Szkurlat J, Bamber S, Baddon AC, Anderson S, Seddon K, Dwyer N, Lovering AM, Smith G
Invest Ophthalmol Vis Sci 2009 Jul;50(7):3176-84. Epub 2009 Feb 14 |
| Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations |
Thomson AH, Staatz CE, Tobin CM, Gall M, Lovering AM
J Antimicrob Chemother 2009 May;63(5):1050-7 |
| Measurements of in vivo intra-articular gentamicin levels from antibiotic loaded articulating spacers in revision total knee replacement |
Mutimer J, Gillespie G, Lovering AM, Porteous AJ
Knee 2009 Jan;16(1):39-41 |
| An HPLC assay for daptomycin in serum |
Tobin CM, Darville JM, Lovering AM, Macgowan AP
J Antimicrob Chemother 2008 Dec;62(6):1462-3 |
| Development, evaluation and application of an isocratic high-performance liquid chromatography (HPLC) assay for the simultaneous determination of aciclovir and its metabolite 9-carboxymethoxymethylguanine in human serum and cerebrospinal fluid |
Darville JM, Lovering AM, MacGowan AP
Int J Antimicrob Agents. 2007 Jul;30(1):30-3. Epub 2007 Apr 10 |
| Evidence of excessive concentrations of 5-flucytosine in children aged below 12years: a 12 year review of serum concentrations from a UK clinical assay reference laboratory |
Soltani M, Tobin CM, Bowker KE, Sunderland, MacGowan AP, Lovering AM
Int J Antimicrob Agents 2006 Dec;28(6):574-7 |
| Assay of ertapenem in human serum by High Performance Liquid Chromotgraphy |
Soltani M, MacGowan AP, Lovering AM
Int J Antimicrob Agents. 2006 Feb;27(2):165-7. Epub 2006 Jan 18 |
| The pharmacokinetics of linezolid in the non-inflamed human eye |
JI Prydal, DR Jenkins, AM Lovering, A Watts
Br J Opthalmol. 2005 Nov; 89, 1418-9 |
| Variability in the content of Indian generic ciprofloxacin eye drops |
Weir RE, Zaidi FH, Charteris DG, Bunce C, Soltani M, Lovering AM
Br J Ophthalmol. 2005 Sep;89(9):1094-6 |
| Residual antibiotics in allograft heart valve tissue samples following antibiotic disinfection |
Leeming JP, Lovering AM, Hunt CJ
J Hosp Infect 2005 Jul;60(3):231-4 |
| Pharmacokinetic studies of linezolid and teicoplanin in the critically ill |
T Whitehouse, JA Cepeda, R Shulman, L Aarons, R Nalda-Molina, C Tobin, AP MacGowan, S Shaw, C Kibbler, M Singer, AP Wilson
J Antimicrob Chemother 2005 Mar; 55, 333-40 |
| Resistance determinants in strains of Clostridium difficile from two geographically distinct populations |
JS Bendle, PA James, PM Bennett, MB Avison, AP MacGowan, KM Al-Shafi
Int J Antimicrob Agents. 2004 Dec; 24, 619-21 |
| Determination of Avilamycin A and B in pig faeces by solid phase extraction and reverse phase extraction |
Sunderland J, Lovering AM, Tobin CM, MacGowan AP, Roe JM, Delsol AA
Int J Antimicrob Agents 2004 Nov;24(5):511-4 |
| Gentamicin concentrations in diagnostic aspirates from 25 patients with hip and knee arthroplasties |
Fletcher MD, Spencer RF, Langkamer VG, Lovering AM
Acta Orthop Scand. 2004 Apr;75(2):173-6 |
| A reverse-phase HPLC assay for the simultaneous determination of enrofloxacin and ciprofloxacin in pig faeces |
Sunderland J, Lovering AM, Tobin CM, MacGowan AP, Roe JM, Delsol AA
Int J Antimicrob Agents. 2004 Apr;23(4):390-3 |
| Topical vancomycin applied on closure of the sternotomy wound does not prevent high levels of systemic vancomycin |
J Desmond, AM Lovering, C Harle, T Djorevic, R Millner
Eur J Card Surg 2003 May;23, 765-70 |
| Determination by HPLC of chlortetracycline in pig faeces |
Sunderland J, Lovering AM, Tobin CM, MacGowan AP, Roe JM, Delsol AA
J Antimicrob Chemother 2003 Apr; 51(4):1041-2 |
| A high performance liquid chromatography assay for linezolid in continuous ambulatory peritoneal dialysis fluid |
CM Tobin, J Sunderland, AM Lovering, AP MacGowan
J Antimicrob Chemother. 2003 51, 1041-2 |
| Variation in the disc content of ciprofloxacin susceptibility testing discs; its effect on the BSAC disc method |
Darville JM, Lovering AM
J Antimicrob Chemother. 2003 Feb; 51(2):465-7 |
| Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement |
Lovering AM,Zhang J, Bannister GC, Lankaster BJ, Brown JH, Narendra G, MacGowan AP
J Antimicrob Chemother 2002 Jul; 50(1):73-7 |
| Epidemiology and resource utilisation for patients hospitalized for lower reapiratory tract infection |
Lovering AM, MacGowan AP, Anderson P, Irwin D
Clin Microbiol Infect 2001 Dec;7(12):666-70 |
| Pharmacokinetics of once-a-day netilmicin (4.5mg/kg) in neonates |
PE Gosden, KA Bedford, JJ Dixon, BD Speidel, AA Leaf, AP MacGowan
J Chemother. 2001 Sep; 13: 270-6 |
| Difficullties in the assay of cefamandole highlight the importance of specific methodologies in pharmacokinetic studies |
Zhang J, Lovering AM
J Antimicrob Chemother. 2001 Jul;48(1):154-5 |
| The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone |
Lovering AM, Walsh TR, Bannister GC, MacGowan AP
J Antimicrob Chemother. 2001 Apr;47(4):483-6 |
| Antimicrobial activity of fluoroquinolone photodegradation products determined by parallel-line bioassay and high performance liquid chromatography |
J Sunderland, CM Tobin, LO White, AP MacGowan, AJ Hedges
J Antimicrob Chemother 2001 Mar; 47: 271-6 |
| Clinafloxacin serum concentrations in a patient on continuous veno-venous haemofiltration |
ES Darley, AP MacGowan, RA Howe, CM Tobin
J Antimicrob Chemother. 2000 Jun;45: 927-8 |
| Teicoplanin therapy for Staphylococcus aureus septicaemia: relationship between pre-dose serum concentration and outcome |
I Harding, AP MacGowan, LO White, ES Darley, V Reed
J Antimicrob Chemother 2000 Jun; 45: 835-42 |
